Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …

Cannabis sativa L. is increasingly emerging for its protective role in modulating
neuroinflammation, a complex process orchestrated among others by microglia, the resident …

The most frequently reported use of medical marijuana is for pain relief. However, its
psychoactive component Δ9-tetrahydrocannabinol (THC) causes significant side effects …

Purpose Cannabis has been used for thousands of years in many cultures for the treatment
of several ailments including pain. The benefits of cannabis are mediated largely by …

Neuropathic pain is a condition that impacts a substantial portion of the population and is
expected to affect a larger percentage in the future. This type of pain is poorly managed by …

Chronic neuropathic pain is a prevalent condition that places a heavy burden on individuals
and the healthcare system. Current medications have limitations and new approaches are …

Cannabidiol (CBD) is a non-psychoactive plant cannabinoid that is clinically used in a 1: 1
mixture with the psychoactive cannabinoid Δ 9-tetrahydrocannabinol (THC) for the treatment …

Background and Purpose Chronic neuropathic pain (NEP) is associated with growing
therapeutic cannabis use. To promote quality of life without psychotropic effects …

Chronic neuropathic pain (NP) is a growing clinical problem for which effective treatments,
aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are …

Cannabis has been shown to be beneficial in the treatment of pain and inflammatory
diseases. The biological effect of cannabis is mainly attributed to two major cannabinoids …